MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ZYME made $105,965K in revenue. -$80,257K in net income. Net profit margin of -75.74%.

Income Overview

Revenue
$105,965K
Net Income
-$80,257K
Net Profit Margin
-75.74%
EPS
-$1.08
Unit: Thousand (K) dollars
Revenue Breakdown
    • Johnson And Johnson Innovative M...
    • Be One Medicines Ltd.-Milestone ...
    • Be One Medicines Ltd.-Recognitio...
    • Others

Income Statement
2025-12-31
Research and development collaborations (note 11)
105,965
Research and development
137,000
General and administrative
61,514
Impairment on ipr&d (note 6)
0
Total operating expenses
198,514
Loss from operations
-92,549
Interest income
13,354
Other (expense) income, net (note 12)
-559
Total other income, net
12,795
Loss before income taxes
-79,754
Income tax (expense) recovery (note 13)
1,376
Net loss
-81,130
Unrealized income (loss) on available for sale securities, net of tax of nil (note 5)
873
Total other comprehensive income (loss)
873
Comprehensive loss
-80,257
Basic EPS
-1.08
Diluted EPS
-1.08
Basic Average Shares
75,404,897
Diluted Average Shares
75,413,396
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized income (loss) onavailable for sale...$873K Comprehensive loss-$80,257K Total othercomprehensive income (loss)$873K Net loss-$81,130K Interest income$13,354K Loss before incometaxes-$79,754K Income tax (expense)recovery (note 13)$1,376K Total other income,net$12,795K Johnson And JohnsonInnovative...$25,000K Be One MedicinesLtd.-Milestone Revenue$20,000K Be One MedicinesLtd.-Recognition Of Deferred...$18,334K GSK-Milestone Revenue$14,000K Bristol MyersSquibb-Option Exercise Fee$7,500K Drug Supply ForOngoing Studies-Jazz$6,548K Jazz-Research SupportPayments And Other...$5,616K Daiichi Sankyo CoLtd-Milestone Revenue$3,100K Jazz-Royalty$2,481K Drug Supply-Jazz$2,103K Be One MedicinesLtd.-Drug Supply$762K Be One MedicinesLtd.-Royalty$271K Merck Sharp DohmeLLC-Research Period...$250K Other (expense)income, net (note 12)-$559K Loss from operations-$92,549K Research and developmentcollaborations (note 11)$105,965K Total operatingexpenses$198,514K Research and development$137,000K General andadministrative$61,514K

Zymeworks Inc. (ZYME)

Zymeworks Inc. (ZYME)